Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)

NCT00002036 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Anti-HIV Immune Serum Globulin (Human)

Sponsor

Abbott